Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.180
-0.020 (-1.67%)
At close: Apr 25, 2025

Duopharma Biotech Berhad Cash Flow Statement

Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
62.6552.6570.1165.6858.61
Upgrade
Depreciation & Amortization
40.5838.7633.4829.6627.56
Upgrade
Other Amortization
4.814.292.722.291.51
Upgrade
Loss (Gain) From Sale of Assets
-0.39--0.01-
Upgrade
Asset Writedown & Restructuring Costs
0.022.43-0.11.1
Upgrade
Provision & Write-off of Bad Debts
-1.434.1-0.490.1-0.82
Upgrade
Other Operating Activities
11.44-7.1122.747.2912.69
Upgrade
Change in Accounts Receivable
-46.6-5.81-13.28-4.144.54
Upgrade
Change in Inventory
-15.35-12.39-53.36-78.43-21.37
Upgrade
Change in Accounts Payable
27.62-28.18.3520.64-12.48
Upgrade
Operating Cash Flow
83.3448.870.2743.271.35
Upgrade
Operating Cash Flow Growth
70.77%-30.54%62.63%-39.45%6.56%
Upgrade
Capital Expenditures
-23.57-32.95-65.18-109.36-56.11
Upgrade
Sale of Property, Plant & Equipment
0.5--0.02-
Upgrade
Sale (Purchase) of Intangibles
-10.32-6.61-5.84-5.64-9.51
Upgrade
Investment in Securities
--6.42--2.072.68
Upgrade
Other Investing Activities
5.972.751.521.21.51
Upgrade
Investing Cash Flow
-27.43-43.23-69.5-115.86-61.43
Upgrade
Long-Term Debt Issued
93.37486.3585.67186.78193.81
Upgrade
Long-Term Debt Repaid
-128.87-369.97-59.27-89.46-158.74
Upgrade
Net Debt Issued (Repaid)
-35.5116.3726.497.3335.07
Upgrade
Common Dividends Paid
-26.93-8.85-8.2-44.96-7.23
Upgrade
Financing Cash Flow
-62.43107.5218.252.3727.83
Upgrade
Foreign Exchange Rate Adjustments
0.56-0.230.690.24-0.4
Upgrade
Net Cash Flow
-5.96112.8719.66-20.0537.36
Upgrade
Free Cash Flow
59.7715.865.08-66.1615.24
Upgrade
Free Cash Flow Growth
276.91%211.98%--12.09%
Upgrade
Free Cash Flow Margin
7.35%2.25%0.73%-10.35%2.67%
Upgrade
Free Cash Flow Per Share
0.060.020.01-0.070.02
Upgrade
Cash Interest Paid
27.0221.7116.5411.976.34
Upgrade
Cash Income Tax Paid
10.6616.8324.5111.6618.12
Upgrade
Levered Free Cash Flow
31.95-10.33-6.71-60.93-7.67
Upgrade
Unlevered Free Cash Flow
48.050.72-1.02-56.91-3.59
Upgrade
Change in Net Working Capital
26.1151.9724.2729.3418.2
Upgrade
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.